Backing the scientific discoveries that shape our future

At IP Group, we see a future enhanced by the impact of transformative businesses we have identified, backed and grown as long-term partners. We’re bold visionaries who are committed to solving some of the world’s greatest unmet needs by transforming ideas into impact, at scale.

Investments with impact

Our Impact Impact left

As one of the most active investors in life sciences, cleantech and deeptech, we’re proud to have developed a strong portfolio of high-growth businesses, several of which have already achieved unicorn status. You may know us as the founder investor in Oxford Nanopore Technologies plc, which hit headlines globally in 2020 for its work in the fight against COVID. Its technology was used for rapid, distributed sequencing of SARS-CoV-2, the virus that causes COVID-19, in more than 85 countries.

Our Impact right

Our portfolio companies share a common goal – to have a positive impact on the world around us, whether that be through life sciences, cleantech (Kiko) or deeptech. Impact really is in our DNA: we’re committed to backing and supporting businesses that bring about a better future. Not only do we generate strong financial returns, the companies we support have a positive social and environmental impact and align closely with the UN’s Sustainable Development Goals.

Our stakeholders are at the heart of all we do

Since pioneering the IP Group model more than two decades ago, we’ve built up a considerable knowledge bank and honed our approach to ensure all stakeholders benefit from the work we do through our portfolio companies.

Investor relations
400 +

companies formed and supported

£ 1.2 bn+

invested in science-based businesses

10,000 +

Jobs created

£ 7 bn+

total value of portfolio companies

Our success wouldn’t be possible without the support of our many stakeholders and we’re proud to have partnered with some of the most prestigious organisations around. From innovative start-ups and visionary founders to investors, co-investors and advisors, our partners are committed to solving the world’s greatest unmet needs, and believe in the power of science to make that happen.